An ALT-negative/telomerase-positive osteosarcoma cell line (MG63) was also tested—this showed that whilst there was some decreased viability in response to silencing of SOD1, the effect was much milder than that observed in ALT-positive osteosarcomas (Fig. 1C). The gene discussed is GPT; the disease is osteosarcoma.